These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15186281)

  • 1. Leiomyoma of the nipple, and normal subareolar muscle fibres, are oestrogen and progesterone receptor positive.
    Chaudhary KS; Shousha S
    Histopathology; 2004 Jun; 44(6):626-8. PubMed ID: 15186281
    [No Abstract]   [Full Text] [Related]  

  • 2. The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact?
    Rhodes A; Jasani B
    J Clin Pathol; 2009 Jan; 62(1):95-6. PubMed ID: 19103868
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome.
    Francis G; Beadle G; Thomas S; Mengersen K; Stein S
    Pathology; 2006 Oct; 38(5):391-8. PubMed ID: 17008275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
    De Maeyer L; Van Limbergen E; De Nys K; Moerman P; Pochet N; Hendrickx W; Wildiers H; Paridaens R; Smeets A; Christiaens MR; Vergote I; Leunen K; Amant F; Neven P
    J Clin Oncol; 2008 Jan; 26(2):335-6; author reply 336-8. PubMed ID: 18182677
    [No Abstract]   [Full Text] [Related]  

  • 5. A huge 'prostate-mimicking' vaginal leiomyoma with simultaneous expression of oestrogen and progesterone receptors.
    Yu DS; Wu ST; Chang CC
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):460-2. PubMed ID: 16953866
    [No Abstract]   [Full Text] [Related]  

  • 6. [Leiomyoma of the breast in the male].
    Winkler S; Stolp A
    Dermatol Monatsschr; 1989; 175(9):588-90. PubMed ID: 2583334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age related.
    Neven P; Pochet N; Drijkoningen M; Amant F; De Smet F; Paridaens R; Christiaens MR; Vergote I
    J Clin Oncol; 2006 Jun; 24(16):2595; author reply 2595-7. PubMed ID: 16735717
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sensitivity and specificity of estrogen receptor, progesterone receptor and HER-2 staining in core biopsies of invasive breast carcinomas.
    Frederik P; Cecile C; Tjalma WA
    Breast J; 2007; 13(4):436-7. PubMed ID: 17593058
    [No Abstract]   [Full Text] [Related]  

  • 10. Pure and mixed hormone receptor positive breast tumors: are they different from therapeutic point of view?
    Altundag K; Altundag O; Gunduz E; Silay YS; Boruban C
    Med Hypotheses; 2005; 65(1):194. PubMed ID: 15893141
    [No Abstract]   [Full Text] [Related]  

  • 11. [Leiomyoma of the nipple (a case report and review of the literature)].
    Laterza E; Veraldi GF; Zannoni M; Ricci F; Poggi C; de Manzoni G; Guglielmi A
    Chir Ital; 1990; 42(3-4):138-42. PubMed ID: 2101342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast cancer.
    McCarthy K; Bustin SA; Ogunkolade B; Khalaf S; Laban CA; McVittie CJ; Carpenter R; Jenkins PJ
    Eur J Surg Oncol; 2006 Sep; 32(7):707-9. PubMed ID: 16650963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of immunohistochemical staining for oestrogen receptor, progesterone receptor and HER-2 in breast core biopsies and subsequent excisions.
    Wood B; Junckerstorff R; Sterrett G; Frost F; Harvey J; Robbins P
    Pathology; 2007 Aug; 39(4):391-5. PubMed ID: 17676479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of oestrogen receptor beta in breast cancer.
    Palmieri C
    Br J Surg; 2000 Sep; 87(9):1248-9. PubMed ID: 10971439
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in oestrogen and progesterone receptors, HER-2, p53 expression and proliferation in ductal breast cancers in relation to histopathological grade.
    Zasławski R; Surowiak P; Paluchowski P; Dziegiel P; Maciejczyk A; Pudełko M; Wojnar A; Zabel M
    Folia Morphol (Warsz); 2005 Feb; 64(1):9-15. PubMed ID: 15832264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of oestrogen receptor negative progesterone receptor positive phenotype in Indian breast cancer: fact or fiction?
    Navani S; Bhaduri AS
    Indian J Pathol Microbiol; 2005 Apr; 48(2):199-201. PubMed ID: 16758664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems with the progesterone receptor in practice?
    Jordan VC; Gelber RD
    J Clin Oncol; 2007 May; 25(15):1957-9. PubMed ID: 17452674
    [No Abstract]   [Full Text] [Related]  

  • 18. Atypical leiomyoma of the urinary bladder--a rare tumor occurring in a young female with concurrent breast carcinoma--an influence of sex steroid hormone?
    Huang HY; Chen WJ; Sung MT; Huang CC
    Scand J Urol Nephrol; 2002; 36(3):231-3. PubMed ID: 12201943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New potential of estrogen and progesterone receptor assay in cytological smears sampled from breast cancer patients].
    Ellinidi VN; Anikeeva NV; Goncharova OA; Novik VI
    Vopr Onkol; 2004; 50(3):355-6. PubMed ID: 15318713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toker cells of the breast. Morphological and immunohistochemical characterization of 40 cases.
    Di Tommaso L; Franchi G; Destro A; Broglia F; Minuti F; Rahal D; Roncalli M
    Hum Pathol; 2008 Sep; 39(9):1295-300. PubMed ID: 18614197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.